Inspire Medical Systems Inc (INSP)
Official siteHEALTHCARE • MEDICAL DEVICES • NYSE
Market Cap: $1.71B
Last updated: Nov 17, 2026 at 4:17 PM ET
Inspire Medical Systems Inc (INSP) Statistics
Inspire Medical Systems (INSP) has a market cap of $1.71B and an enterprise value of $1.52B. It holds $190.80M more cash than debt, 11.14% of its market cap.
Total Valuation
Enterprise value is 11.14% below the market cap, as cash exceeds debt.
| Market Cap | $1.71B |
|---|---|
| Enterprise Value | $1.52B |
| Latest price (Nov 17, 2026) | $59.44 |
Key Dates
The next earnings report is expected on May 3, 2027, covering the quarter ending Mar 31, 2027.
| Next Earnings Date | May 3, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 2, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 2.0x and 2.1x.
| P/E Ratio | 29.3x |
|---|---|
| P/S Ratio | 2.0x |
| Forward P/S | 2.0x |
| P/B Ratio | 2.1x |
| P/FCF Ratio | 17.6x |
| P/OCF Ratio | 12.7x |
| PEG Ratio | 1.4 |
Enterprise Valuation
Counting debt and cash, the company is valued at 46.4x EBITDA and 15.6x free cash flow.
| EV / Earnings | 15.1x |
|---|---|
| EV / Sales | 1.7x |
| EV / EBITDA | 46.4x |
| EV / FCF | 15.6x |
Price Statistics
The stock is down 31.17% over 52 weeks and trades 13.63% below its 50-day average.
| Beta (1Y) | 0.92 |
|---|---|
| 52-Week Change | -31.17% |
| 1-Month Change | -15.27% |
| 3-Month Change | -3.66% |
| 6-Month Change | +39.75% |
| 5-Year Change | -74.74% |
| Total Return (1Y) | -31.17% |
| Total Return (3Y CAGR) | -24.88% |
| Total Return (5Y CAGR) | -25.88% |
| Return vs SPY (1Y) | -40.44% |
| Max Drawdown (1Y) | -72.19% |
| Max Drawdown (3Y) | -84.06% |
| Sharpe Ratio (1Y) | -0.50 |
| Correlation with SPY (1Y) | 0.18 |
| 50-Day Average | $68.82 |
| 200-Day Average | $57.29 |
| 52-Week Range | $38.91 to $147.03 |
| RSI (14 Days) | 34.3 |
| Average Volume (20 Days) | 673.50K |
The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 6.45x current liabilities, and total debt is 0.00x shareholder equity.
| Current Ratio | 6.45x |
|---|---|
| Quick Ratio | 4.61x |
| Debt / Equity | 0.00x |
Returns and Efficiency
Return on equity is 12.18% over the last 12 months, against a 5-year average of -0.94%.
| Return on Equity (ROE) | 12.18% |
|---|---|
| Return on Assets (ROA) | 10.57% |
| ROE (5Y Average) | -0.94% |
| ROA (5Y Average) | -0.53% |
| ROIC (5Y Average) | -4.78% |
| Asset Turnover | 1.00x |
| Inventory Turnover | 0.70x |
| Receivables Turnover | 8.47x |
| Cash Conversion Cycle | 469 days |
Scores
INSP has an Altman Z-Score of 9.56, in the safe zone above 2.99, and a Piotroski F-Score of 6 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 9.56 |
|---|---|
| Altman Z Zone | Safe |
| Piotroski F-Score | 6 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue of $880.94M over the last 12 months is down 0.19% from the 12 months before.
| Revenue | $880.94M |
|---|---|
| Revenue Growth (YoY) | -0.19% |
| Gross Profit | $759.24M |
| Operating Income | $15.76M |
| Pretax Income | $30.82M |
| Net Income | $100.72M |
| EBITDA | $32.96M |
| Reported EPS (TTM) | $2.03 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 86.77% of the $953.03M in total assets.
| Cash and Equivalents | $190.80M |
|---|---|
| Total Debt | $0 |
| Net Cash | $190.80M |
| Net Cash Per Share | $6.60 |
| Working Capital | $530.29M |
| Shareholder Equity | $826.95M |
| Book Value Per Share | $28.59 |
| Total Assets | $953.03M |
| Total Liabilities | $126.08M |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $37.08M of capital spending, operating cash flow left $97.89M of free cash flow.
| Operating Cash Flow | $134.97M |
|---|---|
| Capital Expenditures | $37.08M |
| Free Cash Flow | $97.89M |
| FCF Per Share | $3.39 |
| Depreciation and Amortization | $19.95M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is 1.79%, against a 5-year average of -5.02%.
| Gross Margin | 86.19% |
|---|---|
| Operating Margin | 1.79% |
| Pretax Margin | 3.50% |
| Net Margin | 11.43% |
| EBITDA Margin | 3.74% |
| FCF Margin | 11.11% |
| Gross Margin (5Y Average) | 84.83% |
| Operating Margin (5Y Average) | -5.02% |
| Net Margin (5Y Average) | -1.96% |
Growth
Revenue grew 30.77% a year over 3 years.
| Revenue Growth (3Y CAGR) | +30.77% |
|---|---|
| Revenue Growth (5Y CAGR) | +51.21% |
| FCF Growth (3Y CAGR) | +216.60% |
| Book Value Per Share Growth (2Y CAGR) | +18.83% |
| Tangible Book Per Share Growth (2Y CAGR) | +18.83% |
Dividends and Yields
INSP does not pay a dividend. Its free cash flow yield is 5.69%.
| Earnings Yield | 3.41% |
|---|---|
| FCF Yield | 5.69% |
| Buyback Yield | 2.81% |
| Shareholder Yield | 2.81% |
Peer Position
Against 7 similar companies, INSP has the 4th highest P/E.
P/E RatioPeer median 10.2x
P/S RatioPeer median 2.7x
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +11.95%
| P/E Ratio | 29.3x vs 10.2x median |
|---|---|
| P/S Ratio | 2.0x vs 2.7x median |
| Revenue Growth (Trailing 4 Quarters, YoY) | -0.19% vs +11.95% median |
Analyst Forecast
Consensus estimates put revenue growth at -1.89% and EPS growth at -23.85% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | -1.89% |
|---|---|
| EPS Growth Forecast (2Y CAGR) | -23.85% |
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About INSP
What is INSP's market cap?
Inspire Medical Systems has a market cap of $1.71B. Its enterprise value, which adds debt and subtracts cash, is $1.52B.
What is INSP's P/E ratio?
Inspire Medical Systems has a trailing P/E ratio of 29.3x.
How many shares of INSP are outstanding?
Inspire Medical Systems has 28.93M shares outstanding. The count is down 1.37% from a year earlier.
Does INSP pay a dividend?
No. Inspire Medical Systems does not pay a dividend.
How much debt does INSP have?
Inspire Medical Systems has $0 of total debt and $190.80M of cash and equivalents, a net cash position of $190.80M.
INSP pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors, Government Contracts